MedPath

Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas

Phase 2
Recruiting
Conditions
Neoplasm Metastases
Metastases, Neoplasm
Interventions
Biological: EXTERNAL BEAM RADIATION
Registration Number
NCT05419518
Lead Sponsor
Rutgers, The State University of New Jersey
Brief Summary

The investigators hypothesize that with dose escalation to 40-50 Gy in ten fractions, the complete pain response rate at one month can be increased to 40-50% in painful non-spinal bone metastases. Additionally, the investigators hypothesize that utilizing a fractionation scheme with an escalated biologically equivalent dose (BED) will result in a higher proportion of participants responding to treatment, and will also lead to more durable responses. Furthermore, the investigators hypothesize that with dose escalation to 40-50 Gy in ten fractions, the complete pain response rate at one month can be increased to 35-45% in painful non-bone metastases

Detailed Description

The purpose of this study is to prospectively evaluate dose escalation and pain response in patients with painful non-spinal bone metastases and painful non-bone metastases treated with radiation therapy.

Primary Objective:

To evaluate improvement of complete pain response rate in painful non-spine bone metastases and painful non-bone metastases with dose escalated radiation using a ten fraction radiation regimen

Secondary Objectives:

To evaluate best pain response To evaluate mean pain scores To evaluate the duration of pain response To evaluate the changes in quality-of-life following radiation To evaluate the rates of retreatment with radiation secondary to disease or symptom progression To evaluate treatment related toxicity

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
124
Inclusion Criteria
  • Have provided signed informed consent for the trial
  • Aged ≥18 years at the time of informed consent
  • Histologic proof of malignancy
  • Radiologic or histologic evidence of bone metastases or non-bone metastases
  • Eastern Cooperative Oncology Group (ECOG) Performance Status of ≥3
  • Pain Score ≥ 3
  • Life expectancy of six months or more
  • Willing and able to comply with all aspects of the protocol
  • A female participant is eligible to participate if she is not pregnant and not breastfeeding
  • Woman of childbearing potential who agrees to follow contraceptive guidance during the treatment period and for at least 120 days after the last dose of study treatment.
  • A male participant must agree to use contraception during the treatment period and for at least 120 days after the last dose of study treatment.
Exclusion Criteria
  • Metastasis from a highly radiosensitive tumor (eg, lymphoma, myeloma, germ cell tumor)
  • Spinal metastasis
  • Active compression of spinal cord/cauda equina
  • Previous RT or SBRT to the same site
  • > 3 sites requiring radiation treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Palliative radiation dose escalationEXTERNAL BEAM RADIATIONThe prescribed dose is 50 Gy in 10 fractions. The total dose can be reduced to 40 Gy and the total number of fractions can be reduced to 8 fractions in non-spine metastases to achieve the normal tissue constraints.
Primary Outcome Measures
NameTimeMethod
Safety as assessed by number of participants experiencing adverse eventsOne month

Number of participants experiencing adverse effects grade three or higher, as defined by Common Terminology Criteria for Adverse Effects version 5.0 (CTCAE v5.0)

Secondary Outcome Measures
NameTimeMethod
Severity as assessed by number of participants experiencing toxicity and adverse eventsOne month

This study will utilize the Cancer Therapy Evaluation Program Common Toxicity Criteria (CTC) Version 5.0 for toxicity and Adverse Event reporting

Trial Locations

Locations (6)

RWJBarnabas Health - Saint Barnabas Medical Center

🇺🇸

Livingston, New Jersey, United States

Cancer Institute of New Jersey

🇺🇸

New Brunswick, New Jersey, United States

RWJBarnabas Health - Robert Wood Johnson University Hospital

🇺🇸

Somerset, New Jersey, United States

RWJBarnabas Health - Monmouth Medical Center Southern Campus

🇺🇸

Lakewood, New Jersey, United States

Robert Wood Johnson University Hospital

🇺🇸

New Brunswick, New Jersey, United States

RWJBarnabas Health - Community Medical Center

🇺🇸

Toms River, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath